The aging population of the United States creates pharmaceutical challenges for the practicing emergency physician. Polypharmacy, drug-drug and drug-disease interactions, and other pharmaceutical complications from the pathophysiologic changes associated with aging need to be recognized in order to optimize outcomes in the elderly. Effective strategies that improve patients outcomes include a better understanding of the physiologic and pharmacologic changes that occur with aging, integrated use of clinical emergency department pharmacists, and choosing nonpharmacologic treatment options when possible.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2afml5Q
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose Limited data are available on the relationship between treatment agents and sagittal balance in ankylosing spondylitis ...
-
Abstract The global incidence of very intense cyclones has increased in recent decades with climate projections signaling that this trend ...
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2iguS27
-
Background Traumatic diaphragm injuries (TDI) pose both diagnostic and therapeutic challenges in both the acute and chronic phases. There ar...
-
Objective: To evaluate the effect of routine use of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) on the diagnosis r...
-
Introduction Advancing age is a strong risk factor for adverse outcomes across multiple disease processes. However, septic surgical and trau...
-
Objectives: To review women’s participation as faculty at five critical care conferences over 7 years. Design: Retrospective analysis of fiv...
-
Objectives: To develop and validate an abbreviated version of the Cognitive Failure Questionnaire that can be used by patients as part of s...
-
Publication date: Available online 15 March 2018 Source: The Journal of Emergency Medicine Author(s): Eric J. Rebich, Stephanie S. Lee, J...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου